Neurohormonal activation in populations susceptible to heart failure

Heart Fail Clin. 2005 Apr;1(1):11-23. doi: 10.1016/j.hfc.2004.11.003. Epub 2005 Jan 7.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cardiotonic Agents / therapeutic use
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / metabolism*
  • Cardiovascular Diseases / physiopathology*
  • Catecholamines / metabolism
  • Endothelins / metabolism
  • Heart Failure / drug therapy
  • Heart Failure / metabolism
  • Heart Failure / physiopathology
  • Humans
  • Hypertension / metabolism
  • Hypertension / physiopathology
  • Hypertrophy, Left Ventricular / metabolism
  • Hypertrophy, Left Ventricular / physiopathology
  • Myocardial Infarction / drug therapy
  • Myocardial Infarction / metabolism
  • Myocardial Infarction / physiopathology
  • Natriuretic Peptides / metabolism
  • Neurotransmitter Agents / metabolism*
  • Renin-Angiotensin System
  • Treatment Outcome
  • Ventricular Dysfunction, Left / drug therapy
  • Ventricular Dysfunction, Left / metabolism
  • Ventricular Dysfunction, Left / physiopathology

Substances

  • Cardiotonic Agents
  • Catecholamines
  • Endothelins
  • Natriuretic Peptides
  • Neurotransmitter Agents